does semaglutide interact with antibiotics as a GLP-1 Agonist: A Breakthrough in Obesity Treatment GLP-1 & Antibiotics: Can You

doi: 10.1111/andr.13318

Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease

By encouraging patients to stay active and make mindful dietary choices, they can experience faster weight loss and enhanced overall health

In this section, we will look at the research on the long-term effects of these medications to help answer these important questions